Connecticut Bioscience Innovation Fund

Connecticut Innovations makes equity investments from the $200 million Connecticut Bioscience Innovation Fund to speed commercializable bioscience breakthroughs to market and help healthcare-related companies grow in the state.

Featured Portfolio

Full Portfolio

The Team

Our team partners with innovators to advance the future of health and life sciences.

Matthew Storeygard

Senior Managing Director, Investments and Bio Team Director

Get To Know

Daniel Wagner

Senior Managing Director, Investments

Get To Know

Megha Unhelkar

Director of Investments, Bioscience

Get To Know

Brian Dowd

Director, Investments

Get To Know

Malik Okoro

Senior Associate, Investments

Get To Know

Renee Wasko

Investment Associate

Get To Know

CRITERIA FOR INVESTMENT

CI seeks technology-based companies based in Connecticut or willing to move here. We look for innovators with expertise in bioscience.

Email

contact tamyra davis

primary location

Majority of the company must have a Connecticut presence.

focus on innovation

Companies currently developing a technology.

financial status

Non-recurring revenue from non-grant sources of less than $2 million.

please note

Affiliates or subsidiaries of larger companies, or those that are controlled by common owners from larger companies, are not eligible for pre-seed funding. Meeting the requirements above does not guarantee funding.

Email

contact tamyra davis